[go: up one dir, main page]

NO891046L - Fremgangsmaate for fremstilling av terapeutisk aktive 1,2,4-triazol-derivater. - Google Patents

Fremgangsmaate for fremstilling av terapeutisk aktive 1,2,4-triazol-derivater.

Info

Publication number
NO891046L
NO891046L NO89891046A NO891046A NO891046L NO 891046 L NO891046 L NO 891046L NO 89891046 A NO89891046 A NO 89891046A NO 891046 A NO891046 A NO 891046A NO 891046 L NO891046 L NO 891046L
Authority
NO
Norway
Prior art keywords
alkyl
stands
formula
compounds
het
Prior art date
Application number
NO89891046A
Other languages
English (en)
Norwegian (no)
Other versions
NO891046D0 (no
Inventor
Kurt Schromm
Gerhard Walther
Hubert Heuer
Gojko Muacevic
Franz Birke
Original Assignee
Boehringer Ingelheim Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Kg filed Critical Boehringer Ingelheim Kg
Publication of NO891046D0 publication Critical patent/NO891046D0/no
Publication of NO891046L publication Critical patent/NO891046L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO89891046A 1988-03-12 1989-03-10 Fremgangsmaate for fremstilling av terapeutisk aktive 1,2,4-triazol-derivater. NO891046L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3808283A DE3808283A1 (de) 1988-03-12 1988-03-12 Neue 3,4,5-substituierte 4h-1,2,4-triazole, ihre herstellung und verwendung

Publications (2)

Publication Number Publication Date
NO891046D0 NO891046D0 (no) 1989-03-10
NO891046L true NO891046L (no) 1989-09-13

Family

ID=6349565

Family Applications (1)

Application Number Title Priority Date Filing Date
NO89891046A NO891046L (no) 1988-03-12 1989-03-10 Fremgangsmaate for fremstilling av terapeutisk aktive 1,2,4-triazol-derivater.

Country Status (14)

Country Link
EP (1) EP0335144A1 (xx)
JP (1) JPH01275571A (xx)
KR (1) KR890014525A (xx)
AU (1) AU3119089A (xx)
DD (1) DD283619A5 (xx)
DE (1) DE3808283A1 (xx)
DK (1) DK117089A (xx)
FI (1) FI891153L (xx)
HU (1) HUT51615A (xx)
IL (1) IL89571A0 (xx)
NO (1) NO891046L (xx)
PT (1) PT89977A (xx)
YU (1) YU50689A (xx)
ZA (1) ZA891799B (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991002731A1 (de) * 1989-08-19 1991-03-07 Boehringer Ingelheim Kg Substituierte n-heterocyclen, ihre herstellung und verwendung
WO2001058880A1 (en) * 2000-02-08 2001-08-16 Yamanouchi Pharmaceutical Co., Ltd. Novel triazole derivatives
MXPA02011373A (es) * 2000-05-19 2003-06-26 Yamanouchi Pharma Co Ltd Derivados de triazol.
US6797722B2 (en) * 2002-05-03 2004-09-28 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Use of 3-(2-ethylphenyl)-5-(3-methoxyphenyl)-1H-1,2,4-triazole for the treatment of autoimmune diseases
TW200505913A (en) 2003-03-28 2005-02-16 Hoffmann La Roche Novel oxazole derivatives, their manufacture and use as pharmaceutical agents
US7745630B2 (en) 2003-12-22 2010-06-29 Justin Stephen Bryans Triazolyl piperidine arginine vasopressin receptor modulators
WO2018175324A1 (en) 2017-03-20 2018-09-27 The Broad Institute, Inc. Compounds and methods for regulating insulin secretion
CN110467579B (zh) * 2019-07-30 2020-08-25 浙江理工大学 一种5-三氟甲基取代的1,2,4-三氮唑化合物的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1378617A (en) * 1972-05-05 1974-12-27 Upjohn Co Triazolylbenzophenones
FR2269938A2 (en) * 1974-05-08 1975-12-05 Delalande Sa 5-Hydroxymethyl-3,4-diphenyl-1,2,4-triazoles - with anticholinergic, bronchodilator, antidepressant, analgesic, vasodilator activity, etc.
FR2539127B1 (fr) * 1983-01-10 1985-08-23 Roussel Uclaf Nouveaux derives du 4h-1,2,4-triazole, leur procede de preparation et leur application comme medicaments
YU136287A (en) * 1986-07-25 1990-06-30 Boehringer Kg Process for preparing new 1,4 benzodiazepines

Also Published As

Publication number Publication date
ZA891799B (en) 1990-11-28
KR890014525A (ko) 1989-10-24
NO891046D0 (no) 1989-03-10
YU50689A (en) 1991-04-30
DE3808283A1 (de) 1989-09-21
FI891153A0 (fi) 1989-03-10
IL89571A0 (en) 1989-09-10
HUT51615A (en) 1990-05-28
DK117089D0 (da) 1989-03-10
DD283619A5 (de) 1990-10-17
AU3119089A (en) 1989-09-14
FI891153A7 (fi) 1989-09-13
FI891153L (fi) 1989-09-13
JPH01275571A (ja) 1989-11-06
DK117089A (da) 1989-09-13
EP0335144A1 (de) 1989-10-04
PT89977A (pt) 1989-11-10

Similar Documents

Publication Publication Date Title
US5314883A (en) 5-heteroarylamino-6-oxy-substituted 3(2H)-pyridazinones
US7947707B2 (en) Nitrogenated heterocyclic compound and pharmaceutical composition comprising the same
AU2003230829B2 (en) Triazole derivatives as tachykinin receptor antagonists
FI73670B (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara fenoxialkyl-1,2,4-triazol-3-on derivat.
JP3290657B2 (ja) アンギオテンシンｉｉ拮抗剤として活性な酸性アラルキルトリアゾール誘導体
US4933336A (en) Thiadiazinone, oxadiazinone and triazinone derivatives, and their use for treating acute or chronic heart disease
JP4497815B2 (ja) 新規な複素環式アミド誘導体およびドーパミンｄ３受容体リガンドとしてのその使用
US4618617A (en) Novel 5-substituted 1,2,4,-oxadiazole derivatives and preparation thereof
BRPI0212775B1 (pt) composto de 1,2,4-triazol e medicamento
CA2610310A1 (en) Polycyclic oxadiazoles or isoxazoles and their use as s1p receptor ligands
JP2005533858A (ja) 化合物
NZ223194A (en) 1,2-dihydro-3h-indazol-3-one derivatives and 5-lipoxygenase-inhibiting compositions
CN101273021A (zh) 选择的cgrp拮抗剂、其制备方法及其作为药物的用途
HU217907B (hu) Kinolin- vagy kinazolinszármazékok, eljárás a vegyületek előállítására és a vegyületeket tartalmazó gyógyászati készítmények
JPH04257570A (ja) ピペラジン誘導体
JPH03255063A (ja) セロトニン拮抗剤、それらの製造およびそれらを含有する薬学的組成物
US4857644A (en) Aryl sulfonopiperazines as anti-inflammatory agents
JP2005501826A (ja) 置換イソインドールおよびそれらの使用
IE75733B1 (en) Benzene pyridine and pyrimidine derivative
NO891046L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,2,4-triazol-derivater.
CA2072775A1 (en) Substituted triazolinones
KR102582197B1 (ko) 2-([1,2,3]트리아졸-2-일)-벤조산 유도체의 제조
HU195211B (en) Process for producing 5-alkyl-1-phenyl-2-(piperazinoalkyl)-pyrazolin-3-one derivatives and pharmaceutical preparations comprising the same
Takada et al. Thienylpyrazoloquinolines: potent agonists and inverse agonists to benzodiazepine receptors
JP3012338B2 (ja) アリールおよびヘテロアリールアルコキシナフタレン誘導体